Endoproteinase-protein inhibitor interactions

被引:34
作者
Bode, W [1 ]
Fernandez-Catalan, C
Nagase, H
Maskos, K
机构
[1] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[2] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
关键词
proteinases; proteinase-inhibitor complexes; matrix metalloproteinases (MMPs); tissue inhibitors of metalloproteinases (TIMPs); protein inhibitors; crystal structures;
D O I
10.1111/j.1699-0463.1999.tb01520.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nature uses protein inhibitors as important tools to regulate the proteolytic activity of their target proteinases. Most of these inhibitors for which 3D structures are available are directed towards serine proteinases, interacting with their active-sites in a substrate-like "canonical" manner via an exposed reactive-site loop of conserved conformation. More recently, some non-canonically binding serine proteinase inhibitors, two cysteine proteinase inhibitors, and three zinc endopeptidase inhibitors have been characterized in the free and complexed state, displaying novel mechanisms of inhibition with their target proteinases. These different interaction modes are briefly discussed, with particular emphasis on the interaction between matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors of metalloproteinases (TIMPs).
引用
收藏
页码:3 / 10
页数:8
相关论文
共 40 条
  • [11] Protease inhibitors and carcinogenesis: A review
    Clawson, GA
    [J]. CANCER INVESTIGATION, 1996, 14 (06) : 597 - 608
  • [12] Matrix metalloproteinases and the development of cancer
    Coussens, LM
    Werb, Z
    [J]. CHEMISTRY & BIOLOGY, 1996, 3 (11): : 895 - 904
  • [13] An ester bond linking a fragment of a serine proteinase to its serpin inhibitor
    Egelund, R
    Rodenburg, KW
    Andreasen, PA
    Rasmussen, MS
    Guldberg, RE
    Petersen, TE
    [J]. BIOCHEMISTRY, 1998, 37 (18) : 6375 - 6379
  • [14] Divining the serpin inhibition mechanism: A suicide substrate 'springe'?
    Engh, RA
    Huber, R
    Bode, W
    Schulze, AJ
    [J]. TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) : 503 - 510
  • [15] Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug
    FuentesPrior, P
    NoeskeJungblut, C
    Donner, P
    Schleuning, WD
    Huber, R
    Bode, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 11845 - 11850
  • [16] Gomez DE, 1997, EUR J CELL BIOL, V74, P111
  • [17] Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
    GomisRuth, FX
    Maskos, K
    Betz, M
    Bergner, A
    Huber, R
    Suzuki, K
    Yoshida, N
    Nagase, H
    Brew, K
    Bourenkov, GP
    Bartunik, H
    Bode, W
    [J]. NATURE, 1997, 389 (6646) : 77 - 81
  • [18] X-RAY STRUCTURES OF HUMAN NEUTROPHIL COLLAGENASE COMPLEXED WITH PEPTIDE HYDROXAMATE AND PEPTIDE THIOL INHIBITORS - IMPLICATIONS FOR SUBSTRATE-BINDING AND RATIONAL DRUG DESIGN
    GRAMS, F
    REINEMER, P
    POWERS, JC
    KLEINE, T
    PIEPER, M
    TSCHESCHE, H
    HUBER, R
    BODE, W
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 228 (03): : 830 - 841
  • [19] STRUCTURE DETERMINATION AND ANALYSIS OF HUMAN NEUTROPHIL COLLAGENASE COMPLEXED WITH A HYDROXAMATE INHIBITOR
    GRAMS, F
    CRIMMIN, M
    HINNES, L
    HUXLEY, P
    PIEPER, M
    TSCHESCHE, H
    BODE, W
    [J]. BIOCHEMISTRY, 1995, 34 (43) : 14012 - 14020
  • [20] CRYSTAL-STRUCTURE OF THE THROMBIN HIRUDIN COMPLEX - A NOVEL MODE OF SERINE PROTEASE INHIBITION
    GRUTTER, MG
    PRIESTLE, JP
    RAHUEL, J
    GROSSENBACHER, H
    BODE, W
    HOFSTEENGE, J
    STONE, SR
    [J]. EMBO JOURNAL, 1990, 9 (08) : 2361 - 2365